Skip to main content

Want a detailed portfolio tracker?

Sol-Gel Technologies (SLGL) P/E (2018 - 2026)

Sol-Gel Technologies (SLGL) P/E from Feb 1, 2018 to Jun 2, 2026. The TTM Sol-Gel Technologies (SLGL) P/E is -33.51. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Sol-Gel Technologies (SLGL)

YearP/EChange
2026-33.51+74.96%
2025-19.15+681.87%
2024-2.45+42.99%
2023-1.71-105.23%
202232.75-38.38%
202153.15-791.33%
2020-7.69-43.53%
2019-13.61+1034.92%
2018-1.20N/A

Comparison Sol-Gel Technologies (SLGL) P/E with competitors

Sol-Gel Technologies (SLGL) P/E is -33.51.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.31%
ENLVEnlivex Therapeutics Ltd0.15-100.45%
FGENFibroGen Inc0.24-100.72%
TRAWTraws Pharma Inc0.47-101.41%
FBIOFortress Biotech Inc0.71-102.11%
CHRSCoherus Biosciences Inc0.98-102.92%
ORMPOramed Pharmaceuticals Inc1.47-104.40%
AGENAgenus Inc2.05-106.11%
VIVSVivoSim Labs Inc2.54-107.57%
INVAInnoviva Inc3.19-109.52%
CRMDCorMedix Inc3.65-110.88%
ABEOAbeona Therapeutics Inc4.20-112.55%
VXRTVaxart Inc4.26-112.72%
CVACCureVac N.V.4.45-113.27%
SRPTSarepta Therapeutics Inc4.62-113.80%
GLPGGalapagos NV4.86-114.50%
RIGLRigel Pharmaceuticals4.92-114.68%
ZVRAZevra Therapeutics Inc4.97-114.84%
ABUSArbutus Biopharma Corp5.69-116.99%
CGENCompugen Ltd7.38-122.04%
AUPHAurinia Pharmaceuticals Inc9.25-127.61%
ACADAcadia Pharmaceuticals Inc9.59-128.61%
OMEROmeros Corporation9.88-129.50%
PLXProtalix BioTherapeutics Inc9.91-129.57%
SPROSpero Therapeutics Inc10.73-132.04%
ADMAAdma Biologics Inc11.33-133.82%
SVASinovac Biotech Ltd11.44-134.13%
TBPHTheravance Biopharma Inc11.78-135.15%
HRMYHarmony Biosciences Holdings Inc12.18-136.35%
TGTXTG Therapeutics Inc13.18-139.33%
INCYIncyte Corp13.38-139.94%
SABSSAB Biotherapeutics Inc14.06-141.95%
XOMAXOMA Corp14.95-144.60%
REGNRegeneron Pharmaceuticals Inc14.98-144.71%
PBYIPuma Biotechnology Inc15.05-144.92%
EXELExelixis Inc15.79-147.14%
NAGENiagen Bioscience Inc16.35-148.81%
CPRXCatalyst Pharmaceuticals Inc17.34-151.76%
MDXGMimedx Group Inc17.38-151.86%
ARGXArgen X SE23.07-168.86%
HALOHalozyme Therapeutics Inc23.20-169.24%
XOMAOXOMA Corp25.34-175.64%
VRTXVertex Pharmaceuticals Inc25.66-176.57%
XOMAPXOMA Corp25.67-176.61%
CTMXCytomX Therapeutics Inc25.70-176.69%
ASNDAscendis Pharma A/S26.35-178.65%
RPRXRoyalty Pharma plc - Class A27.50-182.06%
SLNOSoleno Therapeutics Inc29.02-186.59%
LGNDLigand Pharmaceuticals Inc - Class B30.19-190.09%
BMRNBiomarin Pharmaceutical Inc37.51-211.94%
APLSApellis Pharmaceuticals Inc39.02-216.46%
KRYSKrystal Biotech Inc39.70-218.48%
GMABGenmab40.20-219.99%
ONCBeiGene Ltd67.03-300.04%
TECHBio-Techne Corp68.59-304.72%
VCELVericel Corp80.63-340.63%
PHARPharming Group N.V.87.74-361.86%
ALNYAlnylam Pharmaceuticals Inc124.93-472.86%
TLXTelix Pharmaceuticals Ltd139.89-517.50%
CORTCorcept Therapeutics Inc158.39-572.71%